Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes
Cancers · 08.03.2026 · 18 (5) · 870
DOI: 10.3390/cancers18050870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 08.03.2026. Verfasst von Kenta Aso und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Differentiating pancreatic head cancer (PHC) from distal cholangiocarcinoma (dCCA) remains clinically challenging and directly influences treatment strategy. This study evaluates the clinicopathologic features and outcomes of patients with PHC who were preoperatively designated as dCCA.
Methods
We retrospectively analyzed patients undergoing pancreatoduodenectomy for suspected dCCA or PHC from 2019 to 2023. Patients were stratified by pre- and postoperative diagnoses into three groups: confirmed dCCA (B-B), confirmed PHC (P-P), and dCCA reclassified as PHC (B-P). Clinicopathologic features, perioperative outcomes, and survival were compared.
Results
This analysis included 159 patients, B-B = 31, P-P = 115, and B-P = 13. Despite a more advanced stage, a lower R0 rate (p = 0.043), and unplanned portal vein resection confined to B-P (p < 0.001), overall and recurrence-free survival were comparable to P-P (p = 0.363 and 0.183). In multivariable Cox analysis, B-P remained an independent favorable prognostic factor for overall survival (Hazard ratio 0.137, p = 0.020).
Conclusions
Approximately one-third of cases initially diagnosed as dCCA were ultimately PHC. These PHC cases mimicking dCCA demonstrated comparable or even superior survival, suggesting a biologically indolent subset. Refinement of diagnostic criteria and integrated clinicopathologic assessment are essential for optimizing preoperative management strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
- Department of Human Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
ORCID-Profile: Kenta Aso, Shoichi Irie, Yuki Fukumura
Zitieren
APA
Aso, K., Yoshioka, R., Takahashi, A., Irie, S., Takeda, Y., Hirata, Y., Kato, T., Ichida, H., Kotera, Y., Mise, Y., Fukumura, Y., & Saiura, A. (2026). Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes. Cancers, 18(5), 870. https://doi.org/10.3390/cancers18050870
Vancouver
Aso K, Yoshioka R, Takahashi A, Irie S, Takeda Y, Hirata Y, et al. Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes. Cancers. 2026;18(5):870. doi:10.3390/cancers18050870
BibTeX
@article{Aso2026,
author = {Aso, Kenta and Yoshioka, Ryuji and Takahashi, Atsushi and Irie, Shoichi and Takeda, Yoshinori and Hirata, Yoshihiro and Kato, Takaaki and Ichida, Hirofumi and Kotera, Yoshihito and Mise, Yoshihiro and Fukumura, Yuki and Saiura, Akio},
title = {Pancreatic Head Cancer Masquerading as Distal Cholangiocarcinoma: Diagnostic Challenges, Tumor Characteristics, and Oncologic Outcomes},
journal = {Cancers},
year = {2026},
volume = {18},
number = {5},
pages = {870},
doi = {10.3390/cancers18050870}
}
EUVIMED